Abstract:To understand the role of Epstein-Barr virus (EBV) and viral products in associated with immunophenotype and clinical outcome of primary nasopharyngeal carcinoma (NPC), the expression levels of chemokines IFN-g-induced protein 10 (IP-10, CXCL10), stromal-derived factor-1 (SDF-1, CXCL12) and its receptor CXCR4 was investigated in 56 primary NPC biopsy specimens from Chinese NPC patients in parallels with LMP1 antigen and EBER1 by immunohistochemisty (IHC) and in situ hybridization (ISH). Moreover, the expression levels of HLA class I (b-microglobulin) and II antigen (HLA-DR), and co-stimulatory molecule CD54 were also evaluated in 31 out of these 56 patients using immunohistochemisty (IHC). Our results showed that (a) the elevated expression levels of IP10, SDF-1, CXCR4, b-microglobulin, HLA-DR and CD54 in NPC lesions was 66%, 36%, 30%, 42%, 55% and 69%, respectively. (b) High expression of SDF-1 was observed in advanced NPC (N stage, p < 0.05). (c) LMP1 expression correlated with upregulation of CXCR4 and translocation of CXCR4 to the nucleus of the tumor cells. This role of LMP1 in regulating the expression of CXCR4 was confirmed in the EBV positive NPC cell line C666 by inhibition of LMP1 expression with small interfering RNA (siRNA). Our findings provide new insights on the immune status of the malignant cells which may affect the outcome of immunotherapy in NPC. The differentiated nonkeratinizing and undifferentiated types of nasopharyngeal carcinoma (NPC) are associated with Epstein-Barr virus (EBV) in South China, which has the highest incidence rate in the world. The EBV latent type II antigens include nuclear antigen 1 (EBNA1), and latent membrane protein 1 (LMP1, in approximately 50%, seen in ref. 2) and protein 2 (LMP2), in addition small non-polyadenylated viral RNAs non-coding nuclear RNAs (EBERs) and BamHI-A rightward transcripts (BARTs) expressed in NPC tumor cells. The expressions of EBV antigens in NPC tumor cells provide the targets for adoptive immunotherapy. However, the poorly differentiated NPC is always characterized by the presence of a highly cellular lymphoid stroma admixed with tumor cells. However, the role of local immunity surrounding NPC cells and the role EBV and viral products expressed in tumor cell remain unclear, which is associated with the expression of immune-related molecules including chemokines and receptors, HLA class I and II antigens, and co-stimulatory molecules and the role of EBV and viral products to alter the expression of immune-related molecules on tumor cells. It has been reported that the expression pattern of immune related-molecules on tumor cells will affect the outcome of T-cell-based adoptive immunotherapy for NPC.

Correlation Between IL-17A Expression in Nasopharyngeal Carcinoma Tissues and Cells and Pathogenesis of NPC in Endemic Areas

Staining of Interleukin-10 Predicts Clinical Outcome in Patients with Nasopharyngeal Carcinoma.

Relationship Between Mir-338-3p and Clinicopathological Parameters, Prognosis, and STAT3 Mrna Expression in Nasopharyngeal Carcinoma

As an Independent Unfavorable Prognostic Factor, IL-8 Promotes Metastasis of Nasopharyngeal Carcinoma Through Induction of Epithelial–mesenchymal Transition and Activation of AKT Signaling

Effect of IL-17A on the migration and invasion of NPC cells and related mechanisms.

Elevated IL18 levels in Nasopharyngeal carcinoma induced PD-1 expression on NK cells in TILS leading to poor prognosis

MicroRNA-135a Inhibits Nasopharyngeal Carcinoma Cell Proliferation Through Targeting Interleukin-17

Influence of Treg and Th17 Cell in the Tumor Microenvironment on Progression and Prognosis of Nasopharyngeal Carcinoma

Tumor Microenvironment Macrophage Inhibitory Factor Directs the Accumulation of Interleukin-17-producing Tumor-Infiltrating Lymphocytes and Predicts Favorable Survival in Nasopharyngeal Carcinoma Patients.

Detailed analysis of inflammatory cell infiltration and the prognostic impact on nasopharyngeal carcinoma

High PD-L1 Expression Predicts Metastasis in Nasopharyngeal Carcinoma

Integrated Analysis of the Differential Cellular and EBV Mirna Expression Profiles in Microdissected Nasopharyngeal Carcinoma and Non-Cancerous Nasopharyngeal Tissues

Associations of serum CD 62 P and IL-6 levels with nasopharyngeal carcinoma staging and prognosis

Quantification of Epstein-Barr virus DNA load, interleukin-6, interleukin-10, transforming growth factor-β1 and stem cell factor in plasma of patients with nasopharyngeal carcinoma

Expression and Clinical Significance of Programmed Death Ligand 1 in Nasopharyngeal Carcinoma.

[Immunocyte infiltration characteristics of gene expression profile in nasopharyngeal carcinoma and clinical significance]

Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression

Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways

Expression and clinical significance of Ki67 and nm23 in nasopharyngeal carcinoma

Characterization of the nasopharynx microbiota in patients with nasopharyngeal carcinoma vs. healthy controls

Complement receptor 1 expression in peripheral blood mononuclear cells and the association with clinicopathological features and prognosis of nasopharyngeal carcinoma.